and/or
18 News Items found
Decoder
Pictured: Gum ball machines
What Is Tumor Heterogeneity?
Understanding tumor heterogeneity may be the next big quest in cancer science, as differences between cells within a tumor can have important consequences for how cancers are diagnosed and treated.
In the Lab
Pictured: Activated macrophage
Researchers Reveal How Tumors Manipulate Certain Immune Cells to Their Own Advantage
Researchers are exploring a mysterious population of immune cells that live within tumors and can help the cancer grow and spread.
Feature
Pictured: Macrophage & Tumor Cells
Turning to Bacteria for Cancer Clues
Approaches used for research into the social lives of bacteria can also be used to explore how tumors behave and evolve.
Decoder
Blood vessels supply tumors with the nutrients they need to grow.
What Is Angiogenesis?
Cancer biologist Robert Benezra explains angiogenesis, the process by which new blood vessels form, and how it relates to cancer research.
In the Lab
Pictured: Cancer cell on blood vessel
Holding On and Hiding Out: How Cancer Cells Spread to the Brain and Thrive
Researchers have gained new understanding of how tumors metastasize by studying the behavior of exceptional breast and lung cancer cells that are capable of entering the brain and surviving there.
In the Lab
Mouse glioblastoma tumor with phagocytic macrophages
Immune Cells in the Brain Could be Enlisted to Fight Glioblastoma
Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.
Q&A
Pictured: Ming Li
Study Suggests New Ways of Manipulating Immune System to Treat Autoimmune Diseases and Cancer
Recent findings by Memorial Sloan Kettering immunologists might one day pave the way for new strategies to control a range of diseases, including autoimmune disorders and cancer.
In the Lab
Pictured: Breast tumor treated with paclitaxel
Research Suggests New Drugs Could Boost the Effectiveness of Chemotherapy
Recent findings by Memorial Sloan Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.